Tocilizumab: An interleukin-6 receptor antagonist drug
Created 3 weeks ago by marykudro

Tocilizumab is a recombinant humanized anti-human IL-6 (interleukin 6) receptor monoclonal antibody of the immunoglobulin IgG1κ (gamma 1, kappa) subclass with a typical H2L2 polypeptide structure. Healthcare professionals use this drug to treat Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Systemic Juvenile Idiopathic Arthritis, etc.

The strengths in which this medicine is available are 80 mg per 4ml, 200 mg per 10 ml, 400 mg per 20 ml. The medication Tocilizumab 200 mg (and other strengths) is administered via intravenous injection.

https://www.ikrispharmanetwork.com/tocilizumab-actemra/